4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-14-013614
CIK 0001369786operating
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 12:04 PM ET
Size
6.7 KB
Accession
0001181431-14-013614
Insider Transaction Report
Form 4
Patterson Albert
Senior VP, Operations
Transactions
- Award
Common Stock
2014-03-19+841→ 39,174 total - Award
Stock Option to Buy
2014-03-19+1,459→ 1,459 totalExercise: $23.78Exp: 2024-03-19→ Common Stock (1,459 underlying)
Footnotes (1)
- [F1]The option vests in four equal installments beginning on March 19, 2015.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 12:04 PM ET
- Size
- 6.7 KB